Carey J C, Blackwelder W C, Nugent R P, Matteson M A, Rao A V, Eschenbach D A, Lee M L, Rettig P J, Regan J A, Geromanos K L
National Institute of Child Health and Human Development, Bethesda, Maryland.
Am J Obstet Gynecol. 1991 Mar;164(3):728-33. doi: 10.1016/0002-9378(91)90505-l.
To test the hypothesis that genital colonization with Ureaplasma urealyticum would predict adverse pregnancy outcome, 4934 women from five medical centers were evaluated for vaginal colonization with U. urealyticum between 23 and 26 weeks' gestation and followed up to delivery. U. urealyticum colonization was associated with maternal age, parity, racial-ethnic group, martial status, income, education, smoking, number of sexual partners, and colonization with Trichomonas vaginalis, Mycoplasma hominis, and bacterial vaginosis. After adjustment for medical and sociodemographic factors in a multivariate analysis, there was no difference in the mean birth weight or proportion of low-birth-weight infants delivered by women who carried U. urealyticum and those who did not. U. urealyticum colonization at 23 to 26 weeks was not associated with preterm rupture of membranes, preterm labor, or preterm delivery. A positive vaginal culture for U. urealyticum in midgestation does not predict those women at risk for preterm labor, preterm delivery, preterm premature rupture of membranes, or delivery of a low-birth-weight infant.
为了检验解脲脲原体生殖器定植可预测不良妊娠结局这一假设,对来自五个医疗中心的4934名妇女在妊娠23至26周时进行了解脲脲原体阴道定植评估,并随访至分娩。解脲脲原体定植与产妇年龄、产次、种族 - 族裔群体、婚姻状况、收入、教育程度、吸烟、性伴侣数量以及阴道毛滴虫、人型支原体和细菌性阴道病的定植有关。在多变量分析中对医学和社会人口统计学因素进行调整后,携带解脲脲原体的妇女与未携带解脲脲原体的妇女所分娩婴儿的平均出生体重或低出生体重婴儿比例没有差异。妊娠23至26周时解脲脲原体定植与胎膜早破、早产或早产分娩无关。妊娠中期解脲脲原体阴道培养阳性并不能预测哪些妇女有早产、早产分娩、胎膜早破早产或分娩低出生体重婴儿的风险。